Determinants of variability of five programmed death ligand-1 immunohistochemistry assays in non-small cell lung cancer samples

Programmed death ligand-1 (PD-L1) expression as determined by immunohistochemistry (IHC) is potentially predictive of clinical outcome. The aim of this study was to assess the concordance of reported PD-L1 IHC assays and investigate factors influencing variability. Consecutive sections from 20 non-s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Soo, Ross A., Yun Lim, Joey Sze, Asuncion, Bernadette Reyna, Fazreen, Zul, Herrera, Maria Cynthia, Mohd Omar, Mohd Feroz, Diem Phuong, Nguyen Hoang, Seet, Ju Ee, Amanuel, Benhur, Iacopetta, Barry, Byrne, David, Hendry, Shona, Fox, Stephen, Soong, Richie
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5805519/
https://ncbi.nlm.nih.gov/pubmed/29467933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23827
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados